Fund Holdings — Exome Asset Management LLC

Total Portfolio Value
$151.45M
Total Bought
$67.80M
Total Sold
$46.50M
Net Transaction
+$21.30M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
I MAB(NBP)01,439,604+1,439,60405,4423.59%+5,442
ASTRAZENECA PLC(AZN)028,362+28,36204,2702.82%+4,270
CYTOKINETICS INC(CYTK)115,817142,417+26,6003,8277,8275.17%+4,001
IONIS PHARMACEUTICALS INC(IONS)121,116131,016+9,9004,7858,5715.66%+3,786
APOGEE THERAPEUTICS INC(APGE)094,400+94,40003,7512.48%+3,751
ARROWHEAD PHARMACEUTICALS IN(ARWR)0104,507+104,50703,6042.38%+3,604
CVS HEALTH CORP(CVS)043,600+43,60003,2872.17%+3,287
PRAXIS PRECISION MEDICINES I(PRAX)59,002101,996+42,9942,4815,4063.57%+2,925
UNITED THERAPEUTICS CORP DEL(UTHR)06,645+6,64502,7861.84%+2,786
AKERO THERAPEUTICS INC058,579+58,57902,7811.84%+2,781
VERA THERAPEUTICS INC(VERA)76,700156,072+79,3721,8074,5352.99%+2,728
IMMUNOVANT INC(IMVT)0158,622+158,62202,5571.69%+2,557
COGENT BIOSCIENCES INC(COGT)533,647443,547-90,1003,8326,3694.21%+2,538
CYTOMX THERAPEUTICS INC(CTMX)0745,305+745,30502,3781.57%+2,378
ELI LILLY & CO(LLY)4,6737,852+3,1793,6435,9913.96%+2,348
GLAUKOS CORP(GKOS)027,143+27,14302,2141.46%+2,214
LIQUIDIA CORPORATION(LQDA)20,50094,235+73,7352552,1431.41%+1,887
CENCORA INC06,000+6,00001,8751.24%+1,875
89BIO INC233,426273,661+40,2352,2924,0232.66%+1,731
TRAVERE THERAPEUTICS INC(TVTX)153,278156,917+3,6392,2693,7502.48%+1,482
ORIC PHARMACEUTICALS INC(ORIC)0120,644+120,64401,4480.96%+1,448
PROCEPT BIOROBOTICS CORP(PRCT)039,900+39,90001,4240.94%+1,424
INSPIRE MED SYS INC(INSP)018,600+18,60001,3800.91%+1,380
UNIQURE NV(QURE)022,090+22,09001,2890.85%+1,289
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)0178,084+178,08401,2770.84%+1,277
AVALO THERAPEUTICS INC(AVTX)0100,036+100,03601,2710.84%+1,271
EDGEWISE THERAPEUTICS INC(EWTX)124,470173,439+48,9691,6322,8131.86%+1,181
ALUMIS INC0292,770+292,77001,1680.77%+1,168
GUARDANT HEALTH INC(GH)98,18298,18205,1096,1344.05%+1,025
CORBUS PHARMACEUTICALS HLDGS(CRBP)277,317229,962-47,3551,9132,9091.92%+996
UPSTREAM BIO INC(UPB)051,960+51,96009770.65%+977
DISC MEDICINE INC(IRON)61,35661,35603,2494,0542.68%+805
SAREPTA THERAPEUTICS INC(SRPT)2,000,0002,000,00001,4451,7641.17%+319
MBX BIOSCIENCES INC(MBX)63,07652,402-10,6747209170.61%+197
BRIDGEBIO PHARMA INC(BBIO)155,533133,087-22,4466,7166,9134.56%+197
VENTYX BIOSCIENCES INC060,600+60,60001880.12%+188
IMMUNIC INC(IMUX)0173,900+173,90001530.10%+153
KARYOPHARM THERAPEUTICS INC2,000,0002,000,00001,5241,6341.08%+110
ARBUTUS BIOPHARMA CORP(ABUS)75,48475,48402333430.23%+109
10X GENOMICS INC(TXG)163,658163,65801,8951,9131.26%+18
ESTABLISHMENT LABS HLDGS INC(ESTA)13,10013,10005605370.35%-23
PENUMBRA INC(PEN)9,0009,00002,3102,2801.51%-30
MEREO BIOPHARMA GROUP PLC(MREO)14,6000-14,600400—-40
ELEVATION ONCOLOGY INC110,3530-110,353410—-41
CENTESSA PHARMACEUTICALS PLC166,94488,024-78,9202,1942,1351.41%-59
WAYSTAR HLDG CORP(WAY)46,90046,90001,9171,7781.17%-138
NATERA INC(NTRA)18,65018,65003,1513,0021.98%-149
GOSSAMER BIO INC(GOSS)1,097,999451,699-646,3001,3511,1880.78%-163
UNIVERSAL HLTH SVCS INC(UHS)10,1007,955-2,1451,8301,6261.07%-203
SOLENO THERAPEUTICS INC41,64148,445+6,8043,4893,2752.16%-214
ELEDON PHARMACEUTICALS INC(ELDN)114,1450-114,1453090—-309
ANAPTYSBIO INC15,0000-15,0003330—-333
INSTIL BIO INC(TIL)16,2000-16,2003370—-337
VYNE THERAPEUTICS INC(YARW)208,9700-208,9703450—-345
COMPASS PATHWAYS PLC(CMPS)213,5440-213,5445980—-598
INTUITIVE SURGICAL INC6,3586,35803,4552,8431.88%-612
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
36,5740-36,5746620—-662
ALVOTECH(ALVO)78,3720-78,3727150—-715
LEGEND BIOTECH CORP(LEGN)29,1000-29,1001,0330—-1,033
SYNDAX PHARMACEUTICALS INC(SNDX)308,298117,783-190,5152,8871,8121.20%-1,075
TENET HEALTHCARE CORP(THC)27,00018,100-8,9004,7523,6752.43%-1,077
STRUCTURE THERAPEUTICS INC53,7440-53,7441,1150—-1,115
CELLDEX THERAPEUTICS INC NEW(CLDX)73,0000-73,0001,4860—-1,486
BIOCRYST PHARMACEUTICALS INC(BCRX)172,8830-172,8831,5490—-1,549
TRAVERE THERAPEUTICS INC(TVTX)110,0000-110,0001,6280—-1,628
APELLIS PHARMACEUTICALS INC
COM
98,6000-98,6001,7070—-1,707
CRINETICS PHARMACEUTICALS IN(CRNX)62,7000-62,7001,8030—-1,803
REGENXBIO INC(RGNX)226,0600-226,0601,8560—-1,856
DYNE THERAPEUTICS INC(DYN)195,9330-195,9331,8650—-1,865
NEKTAR THERAPEUTICS(NKTR)75,0000-75,0001,9380—-1,938
FULCRUM THERAPEUTICS INC(FULC)444,94998,799-346,1503,0619090.60%-2,152
GERON CORP(GERN)3,414,3771,858,354-1,556,0234,8142,5461.68%-2,268
VERASTEM INC(VSTM)599,9000-599,9002,4900—-2,490
SCHOLAR ROCK HLDG CORP(SRRK)84,3390-84,3392,9870—-2,987
REPLIMUNE GROUP INC(REPL)397,84673,614-324,2323,6963080.20%-3,388
ISHARES TR200,0000-200,0007,3520—-7,352
Page 1 of 1
Exome Asset Management LLC — 13F Holdings — Q3 2025 | TickerTrail